Valneva Se ADR (VALN)

$8.28 +0.09 (1.14%)
Market Cap 669.69M
Revenue (ttm) 183.50M
Net Income (ttm) -13.25M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -7.22%
Debt to Equity Ratio 1.03
Volume 84,832
Avg Vol 54,968
Day's Range N/A - N/A
Shares Out 85.09M
Stochastic %K 53%
Beta 1.77
Analysts Strong Sell
Price Target $13.37

Company Profile

Valneva SE, a specialty vaccine company, develops, manufactures, and commercializes prophylactic vaccines for infectious diseases with unmet needs. It offers IXIARO, an inactivated Vero cell culture-derived Japanese encephalitis vaccine indicated for active immunization against Japanese encephalitis; DUKORAL, an oral vaccine for the prevention of diarrhea caused by Vibrio cholera or heat-labile toxin producing enterotoxigenic Escherichia coli bacterium; and IXCHIQ/ VLA1553, a single-dose, live-a...

Industry: Biotechnology
Sector: Healthcare
Phone: 33 2 28 07 37 10
Fax: 33 2 28 07 37 11
Website: valneva.com
Address:
6 rue Alain Bombard, Saint-Herblain, France
Fishslayer92
Fishslayer92 Aug. 7 at 10:28 AM
$VALN Valneva Reveals Removal of FDA-Recommended Pause on Use of Chikungunya Vaccine IXCHIQ in Elderly and Updates to the Prescribing Information
0 · Reply
Mac24Daddy
Mac24Daddy Aug. 7 at 2:07 AM
$VALN some of us are still here since England trashed our Covid vaccine and crashed the company. Long way to go to get back there fingers crossed. Luckily, this company has the knowledge and foresight that it can save lives with the current outbreak in China. Been here since the days of OTC. Potential is huge.
2 · Reply
MadMusk
MadMusk Aug. 6 at 6:59 PM
$KWEB $OKLO $VALN $SIGA
0 · Reply
MadMusk
MadMusk Aug. 6 at 6:55 PM
$VALN $SPY $QQQ outbreak seems too be bigger Athen anticipated !
0 · Reply
MadMusk
MadMusk Aug. 6 at 5:12 PM
$VALN I was so patient here , Santa:))
0 · Reply
MadMusk
MadMusk Aug. 6 at 5:12 PM
$VALN gimme 20 at least
0 · Reply
MadMusk
MadMusk Aug. 6 at 5:11 PM
$OKLO $VALN bust be 20 with that chins chikugunja Epidemie right now $KWEB
0 · Reply
packcuz
packcuz Aug. 5 at 8:52 PM
$VALN https://www.ladbible.com/news/world-news/chikungunya-virus-china-outbreak-134428-20250805?fbclid=IwQ0xDSwL_ThdleHRuA2FlbQIxMQABHtnmTmjb6xqDm61xneIvOtIlpy6eTrQYwsdJVx2IWWqVEFsv1-WZFnnekOTE_aem_Q_IO0rGH2yKZCJedzEvLKQ
0 · Reply
telemakhos
telemakhos Jul. 30 at 8:28 AM
$VALN https://flutrackers.com/forum/forum/emerging-diseases-other-health-threats-alphabetical-a-thru-h/chikungunya-ab/1014752-france-indigenous-cases-of-chikungunya-2025-on-the-mainland Chikungunya seems to be spreading across mainland France.
0 · Reply
Siuolman58
Siuolman58 Jul. 29 at 11:58 AM
Doctors reveal key signs of Lyme disease as tick season intensifies across US $VALN https://www.foxnews.com/health/doctors-reveal-key-signs-lyme-disease-tick-season-intensifies-across-us
0 · Reply
Latest News on VALN
Valneva Announces Removal of FDA-Recommended Pause on Use of Chikungunya Vaccine IXCHIQ® in Elderly and Updates to the Prescribing Information

Aug 7, 2025, 1:18 AM EDT - 13 hours ago

Valneva Announces Removal of FDA-Recommended Pause on Use of Chikungunya Vaccine IXCHIQ® in Elderly and Updates to the Prescribing Information

AGC Biologics' Heidelberg Site Supplies Drug Substance for Phase II Studies of Valneva's Tetravalent Shigella Vaccine Candidate

Jul 29, 2025, 10:00 AM EDT - 9 days ago

AGC Biologics' Heidelberg Site Supplies Drug Substance for Phase II Studies of Valneva's Tetravalent Shigella Vaccine Candidate

Valneva Announces Lifting of European Medicines Agency's Temporary Restriction on Use of Chikungunya Vaccine IXCHIQ® in Elderly

Jul 11, 2025, 11:35 AM EDT - 27 days ago

Valneva Announces Lifting of European Medicines Agency's Temporary Restriction on Use of Chikungunya Vaccine IXCHIQ® in Elderly

Europe lifts restriction on Valneva's chikungunya vaccine for elderly adults

Jul 11, 2025, 8:18 AM EDT - 27 days ago

Europe lifts restriction on Valneva's chikungunya vaccine for elderly adults

Valneva Announces Exclusive Vaccine Marketing and Distribution Agreement for Germany with CSL Seqirus

Jun 26, 2025, 1:00 AM EDT - 6 weeks ago

Valneva Announces Exclusive Vaccine Marketing and Distribution Agreement for Germany with CSL Seqirus

Valneva Announces Successful Outcome of its Annual General Meeting, Confirms FY 2025 guidance

Jun 25, 2025, 11:45 AM EDT - 6 weeks ago

Valneva Announces Successful Outcome of its Annual General Meeting, Confirms FY 2025 guidance

UK's MHRA suspends Valneva's chikungunya vaccine for elderly

Jun 9, 2025, 10:29 AM EDT - 2 months ago

UK's MHRA suspends Valneva's chikungunya vaccine for elderly

Valneva Reports Positive Six-Month Antibody Persistence and Safety Phase 2 Results in Children for its Single-Shot Chikungunya Vaccine IXCHIQ®

Jun 5, 2025, 11:45 AM EDT - 2 months ago

Valneva Reports Positive Six-Month Antibody Persistence and Safety Phase 2 Results in Children for its Single-Shot Chikungunya Vaccine IXCHIQ®

Valneva Announces Availability of Documentation for its Combined Shareholder Meeting and Provides Corporate Update

Jun 4, 2025, 1:00 AM EDT - 2 months ago

Valneva Announces Availability of Documentation for its Combined Shareholder Meeting and Provides Corporate Update

Valneva to Participate at U.S. and European Investor Conferences in June

May 26, 2025, 11:30 AM EDT - 2 months ago

Valneva to Participate at U.S. and European Investor Conferences in June

Valneva Provides Update on Recommended Use of IXCHIQ® by Elderly Individuals in the United States

May 12, 2025, 1:00 AM EDT - 3 months ago

Valneva Provides Update on Recommended Use of IXCHIQ® by Elderly Individuals in the United States

Valneva SE (VALN) Q1 2025 Earnings Call Transcript

May 9, 2025, 9:47 AM EDT - 3 months ago

Valneva SE (VALN) Q1 2025 Earnings Call Transcript

Valneva SE: Still Undervalued Travel Vaccine Bet With Robust 2025 Guidance

May 8, 2025, 12:30 AM EDT - 3 months ago

Valneva SE: Still Undervalued Travel Vaccine Bet With Robust 2025 Guidance

Valneva Provides Update Following European Medicines Agency Announcement on Use of IXCHIQ® in Elderly

May 7, 2025, 11:45 AM EDT - 3 months ago

Valneva Provides Update Following European Medicines Agency Announcement on Use of IXCHIQ® in Elderly

Europe reviews Valneva's chikungunya vaccine after reports of serious side-effects in older people

May 7, 2025, 8:40 AM EDT - 3 months ago

Europe reviews Valneva's chikungunya vaccine after reports of serious side-effects in older people

Valneva Reports First Quarter 2025 Financial Results and Provides Corporate Updates

May 7, 2025, 1:00 AM EDT - 3 months ago

Valneva Reports First Quarter 2025 Financial Results and Provides Corporate Updates

Valneva Provides Update on Recommendation for Use of Its Chikungunya Vaccine by French Authorities

Apr 26, 2025, 1:10 PM EDT - 3 months ago

Valneva Provides Update on Recommendation for Use of Its Chikungunya Vaccine by French Authorities

Valneva Provides Update on ACIP Recommendation for its Chikungunya Vaccine IXCHIQ® Among U.S. Travelers

Apr 18, 2025, 4:00 AM EDT - 3 months ago

Valneva Provides Update on ACIP Recommendation for its Chikungunya Vaccine IXCHIQ® Among U.S. Travelers

Valneva to Participate in Multiple Events at the 25th World Vaccine Congress, including a Presentation on its Chikungunya Vaccine IXCHIQ®

Apr 16, 2025, 11:45 AM EDT - 4 months ago

Valneva to Participate in Multiple Events at the 25th World Vaccine Congress, including a Presentation on its Chikungunya Vaccine IXCHIQ®

Brazil Approves Valneva's Mosquito-Borne Chikungunya Vaccine

Apr 14, 2025, 2:28 PM EDT - 4 months ago

Brazil Approves Valneva's Mosquito-Borne Chikungunya Vaccine

Valneva Receives First Marketing Authorization for IXCHIQ® in a Chikungunya Endemic Country

Apr 14, 2025, 11:45 AM EDT - 4 months ago

Valneva Receives First Marketing Authorization for IXCHIQ® in a Chikungunya Endemic Country

Valneva and LimmaTech Announce First Vaccination in Phase 2 Infant Study of Tetravalent Shigella Vaccine Candidate S4V2

Apr 9, 2025, 1:00 AM EDT - 4 months ago

Valneva and LimmaTech Announce First Vaccination in Phase 2 Infant Study of Tetravalent Shigella Vaccine Candidate S4V2

VALN Investors Have Opportunity to Join Valneva SE Fraud Investigation with the Schall Law Firm

Apr 7, 2025, 9:33 AM EDT - 4 months ago

VALN Investors Have Opportunity to Join Valneva SE Fraud Investigation with the Schall Law Firm

Valneva SE Shareholding Declaration - March 2025

Apr 3, 2025, 11:45 AM EDT - 4 months ago

Valneva SE Shareholding Declaration - March 2025

Valneva's Chikungunya Vaccine IXCHIQ® Now Authorized in EU for Adolescents Aged 12 and Above

Apr 1, 2025, 11:45 AM EDT - 4 months ago

Valneva's Chikungunya Vaccine IXCHIQ® Now Authorized in EU for Adolescents Aged 12 and Above

Valneva Submits Adolescent Label Extension Application for its Chikungunya Vaccine, IXCHIQ®, to UK MHRA

Mar 31, 2025, 1:00 AM EDT - 4 months ago

Valneva Submits Adolescent Label Extension Application for its Chikungunya Vaccine, IXCHIQ®, to UK MHRA

Valneva Renews its Sales Agreement in connection with its Existing At-the-Market (ATM) Program

Mar 26, 2025, 1:00 PM EDT - 4 months ago

Valneva Renews its Sales Agreement in connection with its Existing At-the-Market (ATM) Program

Valneva Announces Filing of 2024 Universal Registration Document and US Form 20-F

Mar 25, 2025, 2:00 AM EDT - 4 months ago

Valneva Announces Filing of 2024 Universal Registration Document and US Form 20-F

Valneva Responds to French Government's Call for Vaccine Supply of IXCHIQ® against Chikungunya Outbreak in La Réunion

Mar 24, 2025, 2:00 AM EDT - 4 months ago

Valneva Responds to French Government's Call for Vaccine Supply of IXCHIQ® against Chikungunya Outbreak in La Réunion

Valneva SE (VALN) Q4 2024 Earnings Call Transcript

Mar 20, 2025, 8:00 PM EDT - 4 months ago

Valneva SE (VALN) Q4 2024 Earnings Call Transcript

Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Valneva SE (VALN) and Encourages Stockholders to Learn More About the Investigation

Mar 20, 2025, 10:00 AM EDT - 5 months ago

Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Valneva SE (VALN) and Encourages Stockholders to Learn More About the Investigation

Valneva Reports Full Year 2024 Results and Provides Business Updates and Outlook

Mar 20, 2025, 2:00 AM EDT - 5 months ago

Valneva Reports Full Year 2024 Results and Provides Business Updates and Outlook

Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Valneva SE (VALN) And Encourages Shareholders to Reach Out

Mar 19, 2025, 10:00 AM EDT - 5 months ago

Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Valneva SE (VALN) And Encourages Shareholders to Reach Out

Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Valneva SE (VALN) and Encourages Shareholders to Learn More About the Investigation

Mar 18, 2025, 10:00 AM EDT - 5 months ago

Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Valneva SE (VALN) and Encourages Shareholders to Learn More About the Investigation

Valneva SE (VALN) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Contact the Firm to Learn More About the Investigation

Mar 17, 2025, 10:00 AM EDT - 5 months ago

Valneva SE (VALN) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Contact the Firm to Learn More About the Investigation

Bronstein, Gewirtz & Grossman, LLC Encourages Valneva SE (VALN) Shareholders to Inquire about Securities Investigation

Mar 16, 2025, 10:00 AM EDT - 5 months ago

Bronstein, Gewirtz & Grossman, LLC Encourages Valneva SE (VALN) Shareholders to Inquire about Securities Investigation

Bronstein, Gewirtz & Grossman, LLC Is Investigating Valneva SE (VALN) And Encourages Investors to Connect

Mar 14, 2025, 10:00 AM EDT - 5 months ago

Bronstein, Gewirtz & Grossman, LLC Is Investigating Valneva SE (VALN) And Encourages Investors to Connect

Bronstein, Gewirtz & Grossman, LLC Encourages Valneva SE (VALN) Stockholders to Inquire about Securities Investigation

Mar 13, 2025, 10:00 AM EDT - 5 months ago

Bronstein, Gewirtz & Grossman, LLC Encourages Valneva SE (VALN) Stockholders to Inquire about Securities Investigation

Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Valneva SE (VALN) and Encourages Investors to Learn More About the Investigation

Mar 12, 2025, 10:00 AM EDT - 5 months ago

Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Valneva SE (VALN) and Encourages Investors to Learn More About the Investigation

Valneva SE (VALN) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Shareholders to Contact the Firm to Learn More About the Investigation

Mar 11, 2025, 10:00 AM EDT - 5 months ago

Valneva SE (VALN) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Shareholders to Contact the Firm to Learn More About the Investigation

Bronstein, Gewirtz & Grossman, LLC Is Investigating Valneva SE (VALN) And Encourages Stockholders to Connect

Mar 9, 2025, 10:00 AM EDT - 5 months ago

Bronstein, Gewirtz & Grossman, LLC Is Investigating Valneva SE (VALN) And Encourages Stockholders to Connect

Valneva SE (VALN) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Stockholders to Contact the Firm to Learn More About the Investigation

Mar 7, 2025, 10:00 AM EST - 5 months ago

Valneva SE (VALN) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Stockholders to Contact the Firm to Learn More About the Investigation

Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Valneva SE (VALN) and Encourages Stockholders to Learn More About the Investigation.

Mar 6, 2025, 10:00 AM EST - 5 months ago

Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Valneva SE (VALN) and Encourages Stockholders to Learn More About the Investigation.

Bronstein, Gewirtz & Grossman, LLC Encourages Valneva SE (VALN) Investors to Inquire about Securities Investigation

Mar 5, 2025, 10:00 AM EST - 5 months ago

Bronstein, Gewirtz & Grossman, LLC Encourages Valneva SE (VALN) Investors to Inquire about Securities Investigation

Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Valneva SE (VALN) And Encourages Investors to Reach Out

Mar 4, 2025, 1:45 PM EST - 5 months ago

Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Valneva SE (VALN) And Encourages Investors to Reach Out

Fishslayer92
Fishslayer92 Aug. 7 at 10:28 AM
$VALN Valneva Reveals Removal of FDA-Recommended Pause on Use of Chikungunya Vaccine IXCHIQ in Elderly and Updates to the Prescribing Information
0 · Reply
Mac24Daddy
Mac24Daddy Aug. 7 at 2:07 AM
$VALN some of us are still here since England trashed our Covid vaccine and crashed the company. Long way to go to get back there fingers crossed. Luckily, this company has the knowledge and foresight that it can save lives with the current outbreak in China. Been here since the days of OTC. Potential is huge.
2 · Reply
MadMusk
MadMusk Aug. 6 at 6:59 PM
$KWEB $OKLO $VALN $SIGA
0 · Reply
MadMusk
MadMusk Aug. 6 at 6:55 PM
$VALN $SPY $QQQ outbreak seems too be bigger Athen anticipated !
0 · Reply
MadMusk
MadMusk Aug. 6 at 5:12 PM
$VALN I was so patient here , Santa:))
0 · Reply
MadMusk
MadMusk Aug. 6 at 5:12 PM
$VALN gimme 20 at least
0 · Reply
MadMusk
MadMusk Aug. 6 at 5:11 PM
$OKLO $VALN bust be 20 with that chins chikugunja Epidemie right now $KWEB
0 · Reply
packcuz
packcuz Aug. 5 at 8:52 PM
$VALN https://www.ladbible.com/news/world-news/chikungunya-virus-china-outbreak-134428-20250805?fbclid=IwQ0xDSwL_ThdleHRuA2FlbQIxMQABHtnmTmjb6xqDm61xneIvOtIlpy6eTrQYwsdJVx2IWWqVEFsv1-WZFnnekOTE_aem_Q_IO0rGH2yKZCJedzEvLKQ
0 · Reply
telemakhos
telemakhos Jul. 30 at 8:28 AM
$VALN https://flutrackers.com/forum/forum/emerging-diseases-other-health-threats-alphabetical-a-thru-h/chikungunya-ab/1014752-france-indigenous-cases-of-chikungunya-2025-on-the-mainland Chikungunya seems to be spreading across mainland France.
0 · Reply
Siuolman58
Siuolman58 Jul. 29 at 11:58 AM
Doctors reveal key signs of Lyme disease as tick season intensifies across US $VALN https://www.foxnews.com/health/doctors-reveal-key-signs-lyme-disease-tick-season-intensifies-across-us
0 · Reply
LosersMakeMillions
LosersMakeMillions Jul. 28 at 12:24 AM
$VALN current overnight price
0 · Reply
ElizabethDelara121
ElizabethDelara121 Jul. 25 at 7:36 PM
$VALN Institutions don’t chase - they BUILD floors quietly 🧱💼 $3.70–$3.80 range been soaking HARD 💧 You still got a shot before algos flip the switch ⚙️🔥
0 · Reply
BiotechBonesaw
BiotechBonesaw Jul. 24 at 6:07 PM
I asked @ChatGPT_AI who Pfizer will buy next. It said $ALT $VKTX $ACAD or $VALN make sense. 🤯 $PFE : start buying like Merck did! Kickstart this BD. 🚀
1 · Reply
alexpitti
alexpitti Jul. 24 at 1:41 PM
$VALN why stock up 32% since i met with IR on Tuesday
0 · Reply
YogaDouchebag
YogaDouchebag Jul. 24 at 1:39 PM
$VALN Choo Choo
0 · Reply
nroberts7
nroberts7 Jul. 23 at 5:14 PM
$VALN why are we up?
2 · Reply
Filosofem
Filosofem Jul. 23 at 6:33 AM
$VALN https://www.reuters.com/business/healthcare-pharmaceuticals/world-health-organization-raises-concern-about-spread-mosquito-borne-chikungunya-2025-07-22/
0 · Reply
alexpitti
alexpitti Jul. 23 at 12:35 AM
only met with $VALN IR guy. womp womp. solid company though
0 · Reply
alexpitti
alexpitti Jul. 17 at 8:50 PM
$VALN I meeting with management next week. any questions
2 · Reply
ted_the_trader
ted_the_trader Jul. 17 at 9:42 AM
$VALN
0 · Reply
Filosofem
Filosofem Jul. 14 at 2:50 PM
$VALN https://valneva.com/press-release/valneva-announces-lifting-of-european-medicines-agencys-temporary-restriction-on-use-of-chikungunya-vaccine-ixchiq-in-elderly/?lang=de
0 · Reply
Thestocktraderhubzee
Thestocktraderhubzee Jul. 14 at 10:11 AM
WATCHLIST JUL 14 2025. $VALN Valneva's Chikungunya Vaccine IXCHIQ Cleared By European Medicines Agency For Use In Seniors After Safety Committee Review $SOFI TD Cowen Initiates Coverage On SoFi Technologies with Hold Rating, Announces Price Target of $21 $DTCK Davis Commodities Intends To Evaluate Establishment Of Strategic Reserve In Solana, As Part Of Digital Innovation And Treasury Diversification Roadmap $FBK Keefe, Bruyette & Woods Upgrades FB Financial to Outperform, Raises Price Target to $58 $MAG MAG Silver shares are trading higher after the company announced it will be acquired by Pan American Silver Corp for $2.1 billion.
0 · Reply